IRIS

Clinical development of biologicals and biosimilars - safety concerns / Bonovas, S; Peyrin-Biroulet, L; Danese, S. - In: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. - ISSN 1751-2433. - 10:6(2017), pp. 567-569. [10.1080/17512433.2017.1293522]

Clinical development of biologicals and biosimilars - safety concerns

Danese S
2017-01-01
2017
10
6
567
569
3
2-s2.0-85018348381
WOS:000401736000001
Clinical development of biologicals and biosimilars - safety concerns / Bonovas, S; Peyrin-Biroulet, L; Danese, S. - In: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. - ISSN 1751-2433. - 10:6(2017), pp. 567-569. [10.1080/17512433.2017.1293522]
none
3
info:eu-repo/semantics/article
262
Bonovas, S; Peyrin-Biroulet, L; Danese, S
1 Contributo su Rivista::1.1 Articolo in rivista
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/119861
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 11
social impact